Low nuclear proliferative activity is associated with nonmetastatic islet cell tumors

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 2, 2003, Pages 196-199

  Jorda, Merce ^a,b   Ghorab, Zeina ^a   Fernandez, Gustavo ^a   Nassiri, Mehdi ^a   Hanly, Andrew ^a   Nadji, Mehrdad ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CELL KINETICS; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME NOR; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MITOSIS INDEX; PANCREAS ISLET CELL TUMOR; PROTEIN EXPRESSION; RELIABILITY; SCORING SYSTEM;

ADULT; AGED; CARCINOMA, ISLET CELL; CELL DIVISION; CELL NUCLEUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PANCREATIC HORMONES; PANCREATIC NEOPLASMS; PHENOTYPE; PREDICTIVE VALUE OF TESTS;

EID: 0037329814     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lam K, Lo C. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol. 1997;23:36-42.
2. Cubilla A, Hadju S. Islet cell carcinoma. Arch Pathol. 1975;99:204-207.
3. Kloppel G, Heitz P. Pancreatic endocrine tumors. Pathol Res Pract. 1988;183:155-168.
4. Kenny B, Sloan J, Hamilton P, et al. The role of morphometry in predicting prognosis in pancreatic islet cell tumors. Cancer. 1989;64:460-465.
5. Solcia E, Capella C, Buffa R. The contribution of immunochemistry to the diagnosis of neuroendocrine tumors. Semin Diagn Pathol. 1984;1:285-296.
6. Heitz P, Kasper M, Kloppel G, Polak J, Vaitukaitis J. Glycoprotein alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy: immunocytochemical analysis of tumors of 155 patients. Cancer. 1983;51:277-282.
7. Graeme-Cook F, Nardi G, Compton C. Immunocytochemical staining for human chorionic gonadotrophin subunits does not predict malignancy in insulinomas. Am J Clin Pathol. 1990;93:273-276.
8. Viale G, Doglioni C, Gambacorta M, Zamboni G, Coggi G, Bordi C. Progesterone receptor immunoreactivity in pancreatic endocrine tumors: an immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts and skin. Cancer. 1992;70:2268-2277.
9. Lohmann D, Funk A, Niedermeyer H. Identification of P53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;64:293-296.
10. Roncalli M, Springall D, Varndell I, et al. Oncoprotein immunoreactivity in human endocrine tumors. J Pathol. 1991;163:117-127.
11. Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign and malignant human pancreatic tissues. Hum Pathol. 1990;21:607-612.
12. Alanen K, Joensuu H, Klemi P, Marin S, Alavaikko M, Nevalainen T. DNA ploidy in pancreatic neuroendocrine tumors. Am J Clin Pathol. 1990;93:784-788.
13. Donow C, Baisch H, Heitz P, Kloppel G. Nuclear DNA content in 27 pancreatic endocrine tumours: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain. Virchows Arch A Pathol Anat Histopathol. 1991;419:463-468.
14. Ruschoff J, Willemer S, Brunzel M, et al. Nucleolar organizer regions and glycoprotein-hormone alpha-chain reaction as markers of malignancy in endocrine tumors of the pancreas. Histopathology. 1993;22:51-57.
15. Pelosi G, Zamboni G, Doglioni C, et al. Immunodetection of proliferating cell nuclear antigen assesses the growth fraction and predicts malignancy in endocrine tumors of the pancreas. Am J Surg Pathol. 1992;16:1215-1225.
16. Perret A, Mosnier J, Buono J, et al. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol. 1998;109:286-293.
17. Pelosi G, Bresaola E, Bogina G, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol. 1996;27:1124-1134.
18. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-322.
19. Von Herbay A, Sieg B, Schurmann G, Hofmann WJ, Betzler M, Otto HF. Proliferative activity of neuroendocrine tumours of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigations. Gut. 1991;32:949-953.
20. Venkatesh S, Ordonez N, Ajani J, et al. Islet cell carcinoma of the pancreas. Cancer. 1990;65:354-357.